SciELO - Scientific Electronic Library Online

 
vol.18 issue6Accreditation and its implementation in graduate studies in Public HealthScreening program for hemoglobinopathies based on blood donors from Bragança Paulista, São Paulo, Brazil author indexsubject indexarticles search
Home Page  

Cadernos de Saúde Pública

Print version ISSN 0102-311X

Abstract

GRILLO, Laura Brunelli das Neves et al. Mutations in the methylene-tetrahydrofolate reductase gene and Down syndrome. Cad. Saúde Pública [online]. 2002, vol.18, n.6, pp. 1795-1797. ISSN 0102-311X.  http://dx.doi.org/10.1590/S0102-311X2002000600035.

Down syndrome (DS) is a complex genetic and metabolic disorder attributed to the presence of three copies of chromosome 21. The extra chromosome derives from the mother in 93% of cases and is due to abnormal chromosome segregation during meiosis (nondisjunction). Except for advanced age at conception, maternal risk factors for meiotic nondisjunction are not well established. A recent preliminary study suggested that abnormal folate metabolism and the 677 (C®T) mutation in the methylene-tetrahydrofolate reductase (MTHFR) gene may be maternal risk factors for DS. Frequency of the MTHFR 677 (C®T) and 1298 (A®C) mutations was evaluated in 36 mothers of children with DS and in 200 controls. The results are consistent with the observation that the MTHFR 677 (C®T) and 1298 (A®C) mutations are more prevalent among mothers of children with DS than controls. In addition, the most prevalent genotype was the combination of both mutations. The results suggest that mutations in the MTHFR gene are associated with maternal risk for DS

Keywords : Genetics; Down Syndrome; Metabolism.

        · abstract in Portuguese     · text in Portuguese     · pdf in Portuguese